Skip to main content
. 2020 Jun;6(2):216–222. doi: 10.18383/j.tom.2020.00016

Figure 5.

Figure 5.

Receiver operating characteristic curves of SPH in predicting pathologic complete response. SPH measured at pretreatment (A) and SPH measured at early-treatment time point (B). The diagonal line in gray represents a non-discriminatory test (area under the curve = 0.5).